MSON - Misonix, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Misonix, Inc.

1938 New Highway
Farmingdale, NY 11735
United States

IndustryMedical Devices
Full Time Employees92

Key Executives

NameTitlePayExercisedYear Born
Mr. Stavros George Vizirgianakis B.Com.Pres, CEO & Director314.02kN/A1970
Mr. Joseph P. DwyerCFO, Treasurer & Sec.285kN/A1956
Mr. Robert Scott LudeckerSr. VP of Global Sales & Marketing385.62kN/A1967
Mr. Richard A. ZarembaSpecial Projects Mang.254.9k21.24k1955
Mr. Dan VoicVP of R&D and Engineering223.14kN/A1962
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells, as well as other medical devices. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wounds, and maxillo-facial applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

Corporate Governance

Misonix, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.